Strides Pharma Science: The financial results for the period ended September 30, 2026

What happened

Strides Pharma Science (STAR) filed a disclosure with the exchanges on 29 October 2026 at 06:43 PM titled "The financial results for the period ended September 30, 2026".

Company snapshot

Strides Pharma Science is a small-cap company in the Healthcare sector, with a market value of about ₹10,116 crore.

The stock last traded at ₹1,097.5, against a 52-week range of ₹768.7–₹1,260.9 (13.0% below the high).

Before this filing the shares had moved −8.4% over the month and +2.4% over three months. Average daily turnover over the last 20 sessions was about ₹29.53 crore.

Promoters held 27.91% at the end of Q1 FY27; 38.10% of promoter shares were pledged. Foreign institutions owned 28.39% and domestic institutions 15.41%.

What history shows

BCEIE's records show 1 previous results filing from the company since May 2026.

Across 300 similar disclosures by other Healthcare companies, shares moved +1.0% on average the next day and +1.9% over five days; 55% of them rose the next day.

Market-wide, 9,836 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.

Past reactions describe what happened before; they are not a forecast.

What to watch

• Management commentary, margins and order book or guidance in the investor presentation.
• 29 October 2026: Board meeting — Financial Results.

In the news

Recent coverage elsewhere (links open the original publisher):

• Strides Pharma Slips 1.49% to ₹1,044.1 — STAR.NS Holds Above ₹991.89 Support - Swing Entry Signals — https://www.siam.in/, 18 Oct 2026
• Strides Pharma: Q2 FY27 Revenue Jumps 17% to ₹14,297m — InvestyWise, 29 Oct 2026
• Pharma sector stocks today, October 22: Aarti Drugs falls 3.54%, Lupin down 2.39%, Strides Pharma drops 2.27% — Business Upturn, 22 Oct 2026

Source

• Exchange filing (PDF)